Torsten Hombeck Akari Therapeutics PLC (AKTX) insider trading activity

AKTX Quotes by TradingView

Torsten Hombeck is CFO of Akari Therapeutics Plc. Currently has a direct ownership of 200 shares of AKTX, which is worth approximately $272. The most recent transaction as insider was on Jan 10, 2025, when has been sold 200 shares (American Depository Shares representing Ordinary Shares) at a price of $1.22 per share, resulting in proceeds of $244. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 200
n/a 3M change
n/a 12M change
Total Value Held $272

Torsten Hombeck Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 10 2025
BUY
Grant, award, or other acquisition
$244 $1.22 p/Share
200 Added 50.0%
200 American Depository Sh...

Also insider at

AWH
Aspira Women's Health Inc. Healthcare
Chief Financial Officer
TH

Torsten Hombeck

CFO
Austin, TX

Track Institutional and Insider Activities on AKTX

Follow Akari Therapeutics Plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AKTX shares.

Notify only if

Insider Trading

Get notified when an Akari Therapeutics PLC insider buys or sells AKTX shares.

Notify only if

News

Receive news related to Akari Therapeutics Plc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AKTX